Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Bayer AG    BAYN   DE000BAY0017

BAYER AG

(BAYN)
  Report  
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Xetra
07/15/2019 07/16/2019 07/17/2019 07/18/2019 07/19/2019 Date
58.63(c) 59.08(c) 59.01(c) 58.76(c) 59.23 Last
1 750 186 3 092 087 2 027 433 2 115 164 1 257 892 Volume
-0.34% +0.77% -0.12% -0.42% +0.80% Change
More quotes
Financials (EUR)
Sales 2019 46 326 M
EBIT 2019 8 969 M
Net income 2019 3 589 M
Debt 2019 37 607 M
Yield 2019 4,84%
Sales 2020 47 844 M
EBIT 2020 9 941 M
Net income 2020 4 515 M
Debt 2020 35 255 M
Yield 2020 5,14%
P/E ratio 2019 16,8x
P/E ratio 2020 12,3x
EV / Sales2019 2,00x
EV / Sales2020 1,89x
Capitalization 54 965 M
More Financials
Company
Bayer is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Sales are distributed by product family as follows: - healthcare products (56.1%): pharmaceutical products (75.4% of net sales; intended for the prevention and treatment of... 
Sector
Pharmaceuticals
Calendar
07/30Earnings Release
More about the company
Surperformance© ratings of Bayer AG
Trading Rating : Investor Rating :
More Ratings
Latest news on BAYER AG
05:14aBAYER : Syngenta CFO says it faces no glyphosate lawsuits
RE
05:02aBAYER : welcomes judge's call for reduced damages in $2 billion glyphosate case
RE
04:25aBAYER : Correction to Bayer Verdict Article
DJ
03:49aDoes renewables pioneer Germany risk running out of power?
RE
01:42aBAYER : Judge Cuts Third Bayer Roundup Verdict in Tentative Ruling
DJ
07/17BAYER : Leads Investment in U.S. Oncology Startup
DJ
07/17Activist hedge fund Elliott takes stake in UK's Saga
RE
07/16GRAIN HIGHLIGHTS : Top Stories of the Day
DJ
07/16LIVESTOCK HIGHLIGHTS : Top Stories of the Day
DJ
07/16BAYER : moving 500 jobs from North Carolina to St. Louis
AQ
More news
Analyst Recommendations on BAYER AG
More recommendations
Stock Trading Strategies
BAYER - 01/07
The beginning of the move
BUY
More Stock Trading Analysis
Sector news : Pharmaceuticals - NEC
07/18Publicis cuts revenue guidance after disappointing second quarter
RE
07/18ABBVIE : Form 8.3 -
DJ
07/18GLOBAL MARKETS LIVE : Microsoft, Qualcomm, Netflix, Facebook…
07/18MyoKardia Accelerates Timing for Mavacamten Topline Phase 3 Data
DJ
07/18Germany's Merck, Broad Institute Agree on Crispr Intellectual Property Licens..
DJ
More sector news : Pharmaceuticals - NEC
Chart BAYER AG
Duration : Period :
Bayer AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BAYER AG
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 29
Average target price 77,90  €
Last Close Price 58,94  €
Spread / Highest target 109%
Spread / Average Target 32,2%
Spread / Lowest Target -34,2%
EPS Revisions
Managers
NameTitle
Werner Baumann Chairman-Management Board
Werner Wenning Chairman-Supervisory Board
Wolfgang U. Nickl Chief Financial Officer
Katharina Jansen Head-Science & Research
Hartmut Klusik Head-Human Resources, Technology & Sustainability
Sector and Competitors
1st jan.Capitalization (M$)
BAYER AG-2.97%61 703
JOHNSON & JOHNSON2.18%350 096
PFIZER-1.35%237 284
ROCHE HOLDING LTD.10.37%232 441
ROCHE HOLDING12.28%232 441
MERCK AND COMPANY7.21%210 915